Literature DB >> 24072348

Could 68Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas?

Giorgio Treglia1, Luca Giovanella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24072348     DOI： 10.1007/s00259-013-2568-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  20 in total

Review 1.  Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.

Authors:  H J L M Timmers; D Taieb; K Pacak
Journal:  Horm Metab Res       Date:  2012-03-07       Impact factor: 2.936

Review 2.  Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review.

Authors:  V Rufini; G Treglia; P Castaldi; G Perotti; A Giordano
Journal:  Q J Nucl Med Mol Imaging       Date:  2013-06       Impact factor: 2.346

3.  68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.

Authors:  Meeran Naji; Chunlei Zhao; Sarah J Welsh; Richard Meades; Zarni Win; Annalisa Ferrarese; Tricia Tan; Domenico Rubello; Adil Al-Nahhas
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

4.  Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study.

Authors:  Niraj Naswa; Punit Sharma; Aftab Hasan Nazar; Krishan Kant Agarwal; Rakesh Kumar; Ariachery C Ammini; Arun Malhotra; Chandrasekhar Bal
Journal:  Eur Radiol       Date:  2011-10-05       Impact factor: 5.315

5.  Imaging carotid body chemodectomas with ⁶⁸Ga-DOTA-NOC PET-CT.

Authors:  N Naswa; A Kumar; P Sharma; C Bal; A Malhotra; R Kumar
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

Review 6.  Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.

Authors:  Giorgio Treglia; Fabrizio Cocciolillo; Chiara de Waure; Francesco Di Nardo; Maria Rosaria Gualano; Paola Castaldi; Vittoria Rufini; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-23       Impact factor: 9.236

7.  68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.

Authors:  Punit Sharma; Alok Thakar; Sudhir Suman K C; Varun Singh Dhull; Harmandeep Singh; Niraj Naswa; Rama Mohan Reddy; Sellam Karunanithi; Rajeev Kumar; Rakesh Kumar; Arun Malhotra; Chandrasekhar Bal
Journal:  J Nucl Med       Date:  2013-03-21       Impact factor: 10.057

8.  Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

Authors:  Stefano Fanti; Valentina Ambrosini; Paola Tomassetti; Paolo Castellucci; Giancarlo Montini; Vincenzo Allegri; Gaia Grassetto; Domenico Rubello; Cristina Nanni; Roberto Franchi
Journal:  Biomed Pharmacother       Date:  2008-03-03       Impact factor: 6.529

Review 9.  Gallium-68 DOTANOC imaging in paraganglioma/pheochromocytoma: presentation of sample cases and review of the literature.

Authors:  E Lopci; L Zanoni; S Fanti; V Ambrosini; M R Castellani; C Aktolun; A Chiti
Journal:  Q J Nucl Med Mol Imaging       Date:  2013-04-18       Impact factor: 2.346

Review 10.  Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.

Authors:  Håkan Geijer; Lars H Breimer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-20       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.